T1	Participants 62 109	peripheral stage IA non-small cell lung cancer:
T2	Participants 334 377	patients with operable stage IA lung cancer
T3	Participants 1045 1151	n 26 stage I patients, of which 22 were stage 1A, in order to develop and evaluate the planning guidelines
